PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.

Saved in:
Bibliographic Details
Title: PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.
Authors: Escuin-Ordinas H; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Elliott MW; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA., Atefi M; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Lee M; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA., Ng C; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Wei L; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA., Comin-Anduix B; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA., Montecino-Rodriguez E; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, USA., Avramis E; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA., Radu C; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA., Sharp LL; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA ; Current address: Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Dr., San Diego, CA 92121, USA., Ribas A; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA ; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA ; Department of Medicine, Division of Hematology-Oncology, 11-934 Factor Building, Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1782, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2013 Aug 27; Vol. 1, pp. 14. Date of Electronic Publication: 2013 Aug 27 (Print Publication: 2013).
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: eCollection Cited Medium: Print ISSN: 2051-1426 (Print) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24829750
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Escuin-Ordinas+H%22">Escuin-Ordinas H</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Elliott+MW%22">Elliott MW</searchLink>; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Atefi+M%22">Atefi M</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Lee+M%22">Lee M</searchLink>; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ng+C%22">Ng C</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Wei+L%22">Wei L</searchLink>; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Comin-Anduix+B%22">Comin-Anduix B</searchLink>; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Montecino-Rodriguez+E%22">Montecino-Rodriguez E</searchLink>; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Avramis+E%22">Avramis E</searchLink>; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Radu+C%22">Radu C</searchLink>; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Sharp+LL%22">Sharp LL</searchLink>; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA ; Current address: Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Dr., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Ribas+A%22">Ribas A</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA ; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA ; Department of Medicine, Division of Hematology-Oncology, 11-934 Factor Building, Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1782, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2013 Aug 27; Vol. 1, pp. 14. <i>Date of Electronic Publication: </i>2013 Aug 27 (<i>Print Publication: </i>2013).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2051-1426 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24829750
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/2051-1426-1-14
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 14
    Titles:
      – TitleFull: PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Escuin-Ordinas H
      – PersonEntity:
          Name:
            NameFull: Elliott MW
      – PersonEntity:
          Name:
            NameFull: Atefi M
      – PersonEntity:
          Name:
            NameFull: Lee M
      – PersonEntity:
          Name:
            NameFull: Ng C
      – PersonEntity:
          Name:
            NameFull: Wei L
      – PersonEntity:
          Name:
            NameFull: Comin-Anduix B
      – PersonEntity:
          Name:
            NameFull: Montecino-Rodriguez E
      – PersonEntity:
          Name:
            NameFull: Avramis E
      – PersonEntity:
          Name:
            NameFull: Radu C
      – PersonEntity:
          Name:
            NameFull: Sharp LL
      – PersonEntity:
          Name:
            NameFull: Ribas A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 08
              Text: 2013 Aug 27
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-print
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 1
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1